510(k) device
NxStage System One with Cartridge Express (CAR-170-E and CAR-172-E)
Nxstage Medical, Inc. · Dialyzer, High Permeability With Or Without Sealed Dialysate System (KDI, Class II) · First FDA decision Oct 28, 2003, newest Mar 14, 2024Kidney failure and dialysis
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
11
510(k) pathway
Device trials
4
Naming "NxStage"
MAUDE reports
1,566
Brand "NxStage", since 2015
PubMed studies
63
Mentioning "NxStage"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing NxStage System One with Cartridge Express (CAR-170-E and CAR-172-E)
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology, with pictures of the device
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 6 of 11 decisions filed under this name.
K232803 · Decided Mar 14, 2024 · 184 days after receipt
Device type: Dialyzer, High Permeability With Or Without Sealed Dialysate System (KDI) · GI, Urology & Nephrology
5 more FDA decisions with a free account
Older decisions: K122051, K093069, K050525, K041424, K032356
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "NxStage", any status and sponsor, newest update first.
St. Louis UniversityAcademic, hospital or other
NCT03078504 · 6 participants · Start Feb 17, 2017 · Primary completion Jun 6, 2018
Device: continuous renal replacement therapy using System One (TM) setup (Nxstage) · For: Acute Kidney Injury; End-stage Renal Disease
Sites: St Louis, Missouri
3 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "NxStage", and for the whole product code for context.
This brand
1,566 reports: 776 malfunction, 591 injury, 176 death
Whole product code KDI
25,025 reports: 21,247 malfunction, 2,993 injury, 752 death
Newest reports for this brand
- NxStage System OneInjury
3003464075-2026-00099 · Received Oct 30, 2026 · Event dated Oct 20, 2026
Device type: Dialyzer, High Permeability With Or Without Sealed Dialysate System (KDI)
Device problem as coded: Adverse Event Without Identified Device or Use Problem
Patient problem as coded: Vomiting; Dizziness; Syncope/Fainting
4 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Z-0326-2016 · Started Oct 29, 2015
Reason given: Ultrafiltration (UF) Volume software error inaccurate fluid removal
Cause as FDA categorized it: Software Design Change · Device type: Dialyzer, High Permeability With Or Without Sealed Dialysate System (KDI)
3 more recall records with a free account
Published research
The most relevant PubMed records for "NxStage"[tiab]. The summary above synthesizes these.
- Prescribing Home Hemodialysis.
Glickman JD, Teitelbaum I, Golper TA · Adv Chronic Kidney Dis · 2021Review
- The NxStage System One.
Clark WR, Turk JE · Semin Dial · 2004
- Home Hemodialysis: Core Curriculum 2021.
Bieber SD, Young BA · Am J Kidney Dis · 2021Review
- Successful Pregnancy Using the NxStage Home Hemodialysis System.
Brahmbhatt Y, Ikeme A, Bhogal N, et al. · Case Rep Nephrol · 2016
- Thrombocytopenia Occurrence With NxStage vs. Prismaflex Continuous Renal Replacement Systems.
Khorsan R · Cureus · 2025Case Reports
- K+ontrol rapidly and efficiently reduces potassium in donor blood during ex vivo circulation.
Harea GT, Thrailkill M, Garcia I, et al. · Perfusion · 2024Research Support, U.S. Gov't, P.H.S.
- Cost of Dialysis Therapy by Modality in Manitoba.
Beaudry A, Ferguson TW, Rigatto C, et al. · Clin J Am Soc Nephrol · 2018Comparative Study, Research Support, Non-U.S. Gov't
- Use of the B. Braun Hemodialysis Machine to Provide Home Hemodialysis.
Daoui R, Feustel P, Manning C, et al. · Hemodial Int · 2025
- Low-Volume Home Haemodialysis and In-Centre Haemodialysis: Comparison of Dialysis Adequacy in Obese Individuals.
Alalwan AA, Abou Trabeh A, Ahamed MMS, et al. · Cureus · 2023
- An Innovative Approach to Minimizing Downtime in Continuous Kidney Replacement Therapy.
Treu D, Ashenuga M, Massingham K, et al. · ASAIO J · 2023
- Continuous renal replacement therapy machines.
Health Devices · 2008
- NxStage recognizes 10th anniversary of System One FDA approval.
Nephrol News Issues · 2015
Other devices of this type
Also filed under product code KDI.
- Tablo Hemodialysis System (PN-0008000, PN-0006000U)Outset Medical, Inc. · 510(k) 2026
- Aquadex FlexFlow System 2.0Chf Solutions, Inc. · 510(k) 2020
- NxStage Cartridge Express with SpeedswapNxstage Medical, Inc. · 510(k) 2019
- Venofer PumpRenal Solutions, Inc. · 510(k) 2012
- multiFiltratePRO SystemFresenius Medical Care Renal Therapies Group, LLC · 510(k) 2026
- Elisio-HNipro Medical Corporation · 510(k) 2026
- FX CorAL 40Fresenius Medical Care Renal Therapies Group, LLC · 510(k) 2025
- FX CorAL 60 (F00012969)Fresenius Medical Care Renal Therapies Group, LLC · 510(k) 2025
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.